Dapagliflozin after percutaneous aortic valve prosthesis implantation.
INDEPENDENT CLINICAL TRIAL
Clinical trial information
- Promoter: SPANISH SOCIETY OF CARDIOLOGY
- Phase: IV
- Execution start: 22/10/2021
- End of execution: 31/12/2023
- IP: JUAN CABALLERO BORREGO